Inducible Nitric Oxide Synthase Promoter Polymorphism Affords Protection Against Cognitive Dysfunction After Carotid Endarterectomy
Author(s) -
Gene T. Yocum,
John G. Gaudet,
Susie S. Lee,
Yaakov Stern,
Lauren A. Teverbaugh,
Robert R. Sciacca,
Charles W. Emala,
Donald O. Quest,
Paul C. McCormick,
James F. McKinsey,
Nicholas J. Morrissey,
Robert A. Solomon,
E. Sander Connolly,
Éric Heyer
Publication year - 2009
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.108.541177
Subject(s) - medicine , carotid endarterectomy , nitric oxide synthase , gastroenterology , asymptomatic , endarterectomy , cognitive decline , incidence (geometry) , surgery , pathology , nitric oxide , stenosis , disease , dementia , physics , optics
Cognitive dysfunction occurs in 9% to 23% of patients during the first month after carotid endarterectomy (CEA). A 4-basepair (AAAT) tandem repeat polymorphism (either 3 or 4 repeats) has been described in the promoter region of inducible nitric oxide synthase (iNOS), a gene with complex roles in ischemic injury and preconditioning against ischemic injury. We investigated whether the 4-repeat variant (iNOS(+)) affects the incidence of cognitive dysfunction after CEA.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom